We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Immupharma Plc | LSE:IMM | London | Ordinary Share | GB0033711010 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.02 | 0.92% | 2.20 | 2.13 | 2.25 | 2.20 | 2.20 | 2.20 | 91,450 | 10:25:35 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Finance Services | 0 | -3.81M | -0.0114 | -1.93 | 7.33M |
Date | Subject | Author | Discuss |
---|---|---|---|
21/5/2018 18:11 | >> david You make some good points. I try to inject some humour...but clearly it is not appreciated by all! Placebo Effect did prove to be a donkey.... I am always going to respond to the nonsense posted by the normal suspects here because as you say I have strong views. However, happy to not post, if the normal suspects (and muppets) don't. Not much chance of that though......😜 Nobby | nobbygnome | |
21/5/2018 17:25 | You are a humourless bunch 😜 | nobbygnome | |
21/5/2018 17:12 | Just need the smoke like stars in their eyes tonight Matthew I am going to be ........😂 | rnsday | |
21/5/2018 17:06 | Che, you seem to have got yourself a stalker. I hope our Nobby is just the emotional type who has just taken a liking to you. Otherwise its time to get the iron pants and some padlocks if he is the other way inclined LOL. A lonely chap like Nobby, all by himself in a one bed bedsit on the 20th floor at Nelson Mandela house in the big smoke. All he has for company is a couple of top shelf mags, a few tins of the blue nasty and a large picture of Rachel Welch on the wall. This is when internet and social media become so important to these types of people. You see they cannot integrate in normal society, the real Nobby is not much to look at, never mind the zero social skills he has. Hence the personal created on a anonymous board is the best outlet. Here you can become Warren Buffet, Superman or even Super Woman depending on taste for the fetish LOL. No one is none the wiser, you can create a character, lets say you wanted to become a PHD scientist, 30 years in the industry, maybe add a successful investment portfolio to the mix. Become a marathon runner, tell people you have the physical appearance of Tom Cruise etc etc. All you have to do is post it a few times and some people will believe. Now there is a idea Nobby, why do you not just do that LOL LOL LOL. | the_merlion | |
21/5/2018 17:04 | Looks like nobby getting desperate now with the posts from him ...you worried something might be happening very soon 😂What or what are you going to do if they are taken over or it goes to market ...I do worry for you old chap 🤔😂 | rnsday | |
21/5/2018 16:52 | >> che Your horse Placebo Effect should have been on Blackpool Beach. Like Lupuzor the result was dismal.... Nobby | nobbygnome | |
21/5/2018 16:46 | Right have a good evening chaps. Nobby the board clown, you can come out from behind the curtains chap, I am off for the night now LOL. You are such a silly little boy sometimes. | the_merlion | |
21/5/2018 16:40 | Haha I sussed him (Nobby) ages ago, I believe he likes to use names he knows (cartoons, games or fast food outlets) to make user names here. But the text and message are always the same. Do you remember that Dr Biotech, now that was a great one he made LMFAO, what next, maybe Dr Lupus, Dr GSK, Dr KOL, I can not wait to find out, I just hope he veers away from Dr Death or something, that would be plain monotonous. | the_merlion | |
21/5/2018 16:37 | Lol Merlion. It's probably you know who, in his boredom thought that an oriental character would liven his day up!! | brad44 | |
21/5/2018 16:37 | Thanks for the info Ken Chung, for a minute there I thought that was written by our resident clown Nobby. Silly me LOL. Now get my order delivered, otherwise the tip is out of the window today. Furthermore any more lapses like that, and you will soon find yourself sitting next to Nobby at the local MacDonald drive through window. Capisce | the_merlion | |
21/5/2018 16:34 | The Phase 3 trial primary end point was not met. It failed. The best they can hope for now is that after the results of the follow on study in October a partner may help them undertake another Phase 3 trial, although the follow on study could be inconclusive or a flop. If it is inconclusive or a flop, the comnpany will be worthless. If they submit an application for another trial in April 2019, they might start in dosing early 2020, and finish in 2022 or 2023. Such a trial could also be inconclusive or a flop. Still a long way off, lots of risk and basically the headline Phase 3 results from April 2018 are already telling you its a flop. | ken chung | |
21/5/2018 16:17 | What are the charts saying here RSI. | the_merlion | |
21/5/2018 16:13 | Kenny Chungy since your post are alwways negative and repetive, maybe is time not to waste your time over here, unless you want to be the same PARROT time and time again | master rsi | |
21/5/2018 16:09 | Interesting level 2, it views as a back ground order at work to the buy side from Winterflood's. In parallel to this, there seems to be some significant reduction in short positions across the main leveraged providers. | onceatraders | |
21/5/2018 15:58 | Right on time Mr Chung, you have the uncanny knack of knowing Monday is Merlions Chinese take away day. So no. 11, 56 and 13, go easy on the chili sauce and make sure it is piping hot when delivered. I will make the usual pound tip for good service when I have the food delivered. You make the worse investor on the markets (only just piping Nobby) , but no one can touch your sweet and sour LMFAO. Now run along Chung, theres a good chap. | the_merlion | |
21/5/2018 15:54 | Since it failed the Phase 3 trial there must be doubt over the rest of the data and their other drugs and perhaps that explains why they were never progressed. | ken chung | |
21/5/2018 15:53 | Probably all bad data just reconfirming the failure like the headline data did. | ken chung | |
21/5/2018 14:49 | Wigwammer, It is a good observation, there is much more data to be forthcoming from results. | che7win | |
21/5/2018 14:28 | One last thought. There is no placebo control in the extension trial. But what if the number of patients reporting zero anti dsDNA continues to rise? Who cares about a control when patients are being cured? To remind people, the anti dsDNA score is now being used as the de facto standard in the latest lupus trials by both GSK and AZN to determine inclusion in a lupus trial. | wigwammer | |
21/5/2018 13:57 | I believe we are due some updates this week (DYOR). I have increased core holding accordingly. | onceatraders | |
21/5/2018 13:53 | To be clear. This subset were screened for heightened anti dsDNA. In 5 patients out of 70 it went from heightened to zero. Fact. That's a pretty phenomenal placebo :) | wigwammer | |
21/5/2018 13:50 | Two ticks down but no explanation :) | wigwammer |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions